WallStSmart

Amphenol Corporation (APH)vsPlexus Corp (PLXS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Amphenol Corporation generates 501% more annual revenue ($25.90B vs $4.31B). APH leads profitability with a 17.2% profit margin vs 4.3%. APH appears more attractively valued with a PEG of 1.25. APH earns a higher WallStSmart Score of 74/100 (B).

APH

Strong Buy

74

out of 100

Grade: B

Growth: 9.3Profit: 9.0Value: 6.7Quality: 6.0
Piotroski: 4/9Altman Z: 2.36

PLXS

Buy

52

out of 100

Grade: C-

Growth: 6.7Profit: 5.5Value: 4.3Quality: 8.5
Piotroski: 6/9Altman Z: 3.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

APHUndervalued (+51.5%)

Margin of Safety

+51.5%

Fair Value

$296.26

Current Price

$146.78

$149.48 discount

UndervaluedFair: $296.26Overvalued

Intrinsic value data unavailable for PLXS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

APH5 strengths · Avg: 9.0/10
Return on EquityProfitability
32.0%10/10

Every $100 of equity generates 32 in profit

Revenue GrowthGrowth
58.4%10/10

Revenue surging 58.4% year-over-year

Market CapQuality
$182.57B9/10

Large-cap with strong market position

Operating MarginProfitability
27.3%8/10

Strong operational efficiency at 27.3%

EPS GrowthGrowth
24.1%8/10

Earnings expanding 24.1% YoY

PLXS4 strengths · Avg: 8.8/10
Altman Z-ScoreHealth
3.2410/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
18.7%8/10

18.7% revenue growth

EPS GrowthGrowth
29.1%8/10

Earnings expanding 29.1% YoY

Areas to Watch

APH3 concerns · Avg: 3.0/10
Price/BookValuation
12.9x4/10

Trading at 12.9x book value

Debt/EquityHealth
1.343/10

Elevated debt levels

P/E RatioValuation
42.5x2/10

Premium valuation, high expectations priced in

PLXS3 concerns · Avg: 3.0/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
43.1x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : APH

The strongest argument for APH centers on Return on Equity, Revenue Growth, Market Cap. Profitability is solid with margins at 17.2% and operating margin at 27.3%. Revenue growth of 58.4% demonstrates continued momentum.

Bull Case : PLXS

The strongest argument for PLXS centers on Altman Z-Score, Debt/Equity, Revenue Growth. Revenue growth of 18.7% demonstrates continued momentum.

Bear Case : APH

The primary concerns for APH are Price/Book, Debt/Equity, P/E Ratio. A P/E of 42.5x leaves little room for execution misses.

Bear Case : PLXS

The primary concerns for PLXS are PEG Ratio, Profit Margin, P/E Ratio. A P/E of 43.1x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

APH carries more volatility with a beta of 1.30 — expect wider price swings.

APH is growing revenue faster at 58.4% — sustainability is the question.

APH generates stronger free cash flow (830M), providing more financial flexibility.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

APH scores higher overall (74/100 vs 52/100), backed by strong 17.2% margins and 58.4% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amphenol Corporation

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Amphenol Corporation is a major producer of electronic and fiber optic connectors, cable and interconnect systems such as coaxial cables. Amphenol is a portmanteau from the corporation's original name, American Phenolic Corp.

Plexus Corp

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Plexus Corp. The company is headquartered in Neenah, Wisconsin.

Visit Website →

Want to dig deeper into these stocks?